Gastrointestinal perforation induced by bevacizumab treatment in cervix carcinoma

Gastrointestinal perforation induced by bevacizumab treatment in cervix carcinoma

Bibliographic Details
Main Authors:	Elisabet Nogué-Pujadas, Clara Lezcano-Rubio, David López-Sisamón, Margarita Romeo-Marín
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2015-11-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/9651.pdf

Similar Items

Gastrointestinal perforations in a patient treated by Bevacizumab and chemotherapy: Is it an anaphylactic reaction?
by: Wen-Ling Lee, et al.
Published: (2020-07-01)

Bevacizumab‐associated intestinal perforation and perioperative complications in patients receiving bevacizumab
by: Toshiaki Yoshimoto, et al.
Published: (2020-03-01)

Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
by: Yuri Nakao, et al.
Published: (2020-04-01)

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?
by: Klag N, et al.
Published: (2016-06-01)

Carcinoma de Cérvix
by: Guillermo López Escobar, et al.
Published: (1961-12-01)

Double Perforation after Colorectal Cancer Surgery During Bevacizumab Treatment
by: Lucian Sorin ANDREI, et al.
Published: (2020-12-01)

OTSC® system for the treatment of gastrointestinal perforations
by: J.O. Alonso-Lárraga, et al.
Published: (2017-07-01)

Carcinoma de cérvix y embarazo Carcinoma of the cervix associated with pregnancy
by: Gildardo Gallego Noreña, et al.
Published: (1994-04-01)

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer
by: Michiko Nonaka, et al.
Published: (2018-11-01)

Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
by: Jia Li, et al.
Published: (2009-09-01)

Sarcomatoid carcinoma of the cervix
by: Tahani H. Nageeti, et al.
Published: (2012-09-01)

Microinvasive carcinoma of the cervix
by: Živaljević Milica, et al.
Published: (2004-01-01)

Change in treatment policy for neonatal gastrointestinal perforations
by: V. A. Savvina, et al.
Published: (2016-03-01)

Management of gastrointestinal tract perforations
by: Yunho Jung
Published: (2017-10-01)

Intestinal Perforation after Bevacizumab Treatment in Metastatic Colon Cancer: A Rare Case
by: Durmuş Ali Çetin, et al.
Published: (2016-03-01)

A review of duodenal metastases from squamous cell carcinoma of the cervix presenting as an upper gastrointestinal bleed
by: Diudea Dana, et al.
Published: (2011-09-01)

Adenoid Cystic Carcinoma of Cervix: Treatment Strategy
by: Paramjeet Kaur, et al.
Published: (2013-11-01)

Gastropleural fistula from gastric perforation due to renal cell carcinoma after bevacizumab chemotherapy: a case report
by: Olivia Meira Dias, et al.
Published: (2011-01-01)

MR imaging of carcinoma cervix
by: Mangal Mahajan, et al.
Published: (2013-07-01)

Carcinoma in-situ del cérvix
by: German Jordan, et al.
Published: (1971-04-01)

Microinvasive carcinoma of the uterine cervix
by: Špela Srkolj, et al.
Published: (2011-06-01)

Carcinoma in situ del cérvix
by: Haroldo Calvo Núñez, et al.
Published: (1951-02-01)

Adenoid cystic carcinoma of the cervix.
by: Dixit S, et al.
Published: (1993-10-01)

Tuberculosis of Uterine Cervix Presenting with Recurrent Leucorrhoea in Guise of Carcinoma of Cervix
by: Rajnandini Prasad, et al.
Published: (2019-11-01)

Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment
by: Efnan Algin, et al.
Published: (2016-08-01)

Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature
by: Yusuke Fujii, et al.
Published: (2018-03-01)

Bowel Perforation in the Emergency Department Related to Bevacizumab Therapy and Recurrent Ovarian Cancer
by: Stuart A. Ostby, et al.
Published: (2020-05-01)

Endoscopic management of iatrogenic gastrointestinal perforations
by: Kan Wang, et al.
Published: (2019-06-01)

Carcinoma intra-epitelial del cervix uterino
by: Guillermo López Escobar, et al.
Published: (1958-08-01)

Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
by: Muaaz Masood, et al.
Published: (2021-01-01)

Bevacizumab for Refractory Gastrointestinal Bleeding in Rendu-Osler-Weber Disease
by: Carlos Bernardes, et al.
Published: (2017-10-01)

Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix
by: F Paton, et al.
Published: (2010-05-01)

COMPLICATIONS AT THE OPERATIVE TREATMENT OF THE INVASIVE CERVIX UTERI CARCINOMA
by: Radomir Živadinović, et al.
Published: (2002-09-01)

Lesiones distróficas y carcinoma in-situ del cervix
by: G. Lopéz-Escobar, et al.
Published: (1957-10-01)

Studies on experimental carcinoma of the uterine cervix /
by: Scarpelli, Dante G.
Published: (1960)

Invasive Micropapillary Carcinoma of the Uterine Cervix
by: Hyun Hee Koh, et al.
Published: (2020-12-01)

Psychiatric morbidities in patients of carcinoma cervix
by: Adya Shanker Srivastava, et al.
Published: (2017-12-01)

Large-cell neuroendocrine carcinoma of the cervix
by: Arkadiusz Z. Dudek, et al.
Published: (2012-01-01)

Carcinoma of the cervix : molecular genetic analysis
by: Busby-Earle, R. M. Camille
Published: (1994)

Pathogenesis of carcinoma of cervix molecular approach.
Published: (1992)